首页> 外国专利> DS-IFA-VICH-AT-SROK ENZYME IMMUNOASSAY SYSTEM FOR DETERMINING PROBABLE TIME OF INTRODUCTION OF TYPE 1 HUMAN IMMUNODEFICIENCY VIRUS (HIV-1) INFECTION, INCLUDING GROUP O HIV-1 IN HUMAN SERUM (PLASMA)

DS-IFA-VICH-AT-SROK ENZYME IMMUNOASSAY SYSTEM FOR DETERMINING PROBABLE TIME OF INTRODUCTION OF TYPE 1 HUMAN IMMUNODEFICIENCY VIRUS (HIV-1) INFECTION, INCLUDING GROUP O HIV-1 IN HUMAN SERUM (PLASMA)

机译:DS-IFA-VICH-AT-SROK酶免疫分析系统,用于确定引入1型人类免疫缺陷病毒(HIV-1)感染的可能时间,包括人类血清(血浆)中的HIV-1组

摘要

FIELD: medicine.;SUBSTANCE: enzyme immunoassay system for determining a probable time of the introduction of type 1 human immunodeficiency virus (HIV-1) infection, including group O HIV-1 in human serum (plasma). The system contains an immunosorbent of type 1 human immunodeficiency virus antigens (env HIV-1 and group O HIV-1), an assay diluent (PPC) and detecting reagents (conjugates, chromogen/substrate). The invention refers to a method for determining the probable time of the introduction of type 1 human immunodeficiency virus (HIV-1) infection, including group O HIV-1 in human serum (plasma) by analysing patient's blood serum with using the above enzyme immunoassay system.;EFFECT: invention enables the fast and simple determination of the probable time of the introduction of the HIV infection.;2 cl, 4 tbl, 2 ex
机译:领域:药物:酶免疫测定系统,用于确定1型人免疫缺陷病毒(HIV-1)感染(包括人血清(血浆)中的O HIV-1组)引入的可能时间。该系统包含1型人类免疫缺陷病毒抗原(env HIV-1和O HIV-1组)的免疫吸附剂,测定稀释剂(PPC)和检测试剂(结合物,色原/底物)。本发明涉及一种通过使用上述酶免疫测定法分析患者的血清来确定在人血清(血浆)中引入包括人O型HIV-1的1型人免疫缺陷病毒(HIV-1)感染的可能时间的方法。系统:效果:本发明能够快速,简单地确定引入HIV感染的可能时间。2cl,4 tbl,2 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号